Life Science News

RSS

Thermo Fisher Scientific launches Acclaim Surfactant Plus and MAbPac SCX-10 chromatography columns

Thermo Fisher Scientific Inc., the world leader in serving science, today introduced new chromatography columns, the Thermo Scientific Acclaim Surfactant Plus and smaller-particle sized Thermo Scientific MAbPac SCX-10.

From Thermo Fisher Scientific Inc. 12 Mar 2012

Thermo Fisher Scientific introduces new ICP-MS system, iCAP Q

Thermo Fisher Scientific Inc., the world leader in serving science, today launched its new Thermo Scientific iCAP Q, an ICP-MS system that features world-class performance and increased throughput to help laboratories cut analysis times by up to 50 percent when compared to the XSERIES 2 ICP-MS, the model it replaces.

From Thermo Fisher Scientific Inc. 12 Mar 2012

China's SFDA approves Dynex DS2 ELISA analyzer

Dynex Technologies announced today it has received approval from China's State Food and Drug Administration (SFDA) to market the DS2 automated enzyme-linked immunosorbent assay (ELISA) analyzer in China.

From Thermo Fisher Scientific Inc. 22 Feb 2012

RUCDR, PerkinElmer partner to automate NGS sample preparation

PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that the Rutgers University Cell and DNA Repository (RUCDR), the largest cell and DNA biobank in the United States, has adopted the Company's technologies for automation of Next Generation Sequencing (NGS) sample preparation.

From PerkinElmer 16 Feb 2012

Study underscores power of real-time cell monitoring to dissect pluridimensionality of GPCR signaling

A research team led by Dr. Michel Bouvier at the Institute for Research in Immunology and Cancer (IRIC) of the University of Montreal in Quebec, used the Roche xCELLigence SP Instrument to measure changes in cell response following ligand stimulation.

From Roche Diagnostics Limited 16 Feb 2012

PerkinElmer launches new AlphaLISA Epigenetic Cellular Detection Kits

At the 1st annual Society for Laboratory Automation and Screening Conference in San Diego, PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of four new cellular assay kits to help identify and characterize possible drug candidates targeting epigenetic enzymes related to key disease states.

From PerkinElmer 7 Feb 2012

PerkinElmer to showcase new drug discovery technologies at SLAS conference

At the 1st annual Society for Laboratory Automation and Screening Conference in San Diego (Booth #711), PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, will be showcasing several new drug discovery technologies and applications - including innovative products based on the Company's ALPHA technology and LANCE Ultra technologies for epigenetics research.

From PerkinElmer 4 Feb 2012

Thermo Fisher Scientific introduces new handheld narcotics analyzer

Thermo Fisher Scientific Inc., the world leader in serving science, today introduced Thermo Scientific TruNarc, a new handheld narcotics analyzer that gives local law enforcement a significant technology edge in the war on drugs.

From Thermo Fisher Scientific Inc. 3 Feb 2012

Thermo Fisher fourth quarter revenues increase 15% to $3.13B

Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2011.

From Thermo Fisher Scientific Inc. 1 Feb 2012

Technoclone, Roche enter strategic alliance to co-develop coagulation assays

Roche announced today that it has entered into a strategic alliance with Technoclone, a reagent specialist in thrombosis and cardiovascular diagnostics based in Vienna, Austria, to co-develop a complete range of coagulation assays.

From Roche Diagnostics Limited 27 Jan 2012

Roche proposes to acquire Illumina for $44.50 per share

Roche announced today that it is proposing to acquire all outstanding shares of Illumina, Inc. for $44.50 per share in cash, or an aggregate of approximately $5.7 billion on a fully diluted basis.

From Roche Diagnostics Limited 24 Jan 2012

Courtagen announces acquisition of Medicinal Genomics

Courtagen Life Sciences, Inc., a privately held life sciences company that provides innovative proteomic and genomic products and services to the life sciences industry, announced today that it has acquired Medicinal Genomics Corporation, with operations in Marblehead, Mass. and Amsterdam, Netherlands.

From Beckman Coulter Life Sciences - Automation and Genomics 18 Jan 2012

South West Water selects PerkinElmer's NexION 300 ICP-MS instrument

PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, has provided South West Water, a UK-based water utility, its NexION 300 ICP-MS platform to help ensure and deliver safe water to 1.6 million people and businesses in the south west of England through advanced analytical monitoring.

From PerkinElmer 13 Jan 2012

PerkinElmer to showcase Columbus 2.3 platform at High Content Analysis Conference

PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, will showcase the enhanced Columbus 2.3 Image Data Storage and Analysis System at the High Content Analysis Conference in San Francisco.

From PerkinElmer 11 Jan 2012

Proteomics: Thermo Fisher Scientific and PREMIER Biosoft to co-market SimGlycan software

Thermo Fisher Scientific Inc., the world leader in serving science, and PREMIER Biosoft, have announced an agreement to co-market PREMIER Biosoft’s SimGlycan® software. The agreement aims to advance glycobiology by dramatically speeding the characterization of complex glycans through automated interpretation of the rich data produced by Thermo Scientific mass spectrometer systems.

From Thermo Fisher Scientific Inc. 8 Jan 2012

Thermo Fisher Scientific's Unity Lab Services to optimize productivity and reduce costs

Thermo Fisher Scientific Inc., the world leader in serving science, today introduced Unity Lab Services, a new offering that combines product and laboratory support services to create a single solution for customers to optimize productivity and reduce their total cost of laboratory operations.

From Thermo Fisher Scientific Inc. 7 Jan 2012

Olympus adds dissolvable sinus spacing and hemostat products to ENT portfolio

Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, today announced the addition of a broad line of advanced, dissolvable sinus spacing and hemostat products to its already extensive ENT product portfolio. These products include spacers, foams and powders available in either plant-based or chitosan polysaccharide polymers.

From Olympus Life Science Solutions 6 Jan 2012

PerkinElmer's ViaCord enters collaborative study with Miracle Babies

PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced today that its family cord blood banking business, ViaCord, entered into a collaborative study with Miracle Babies, a non-profit organization supporting families with newborns in Neonatal Intensive Care Units.

From PerkinElmer 20 Dec 2011

Olympus introduces EZ Shot 2 single-use aspiration needles for Endoscopic Ultrasound procedures

Olympus America Inc. today expanded its medical portfolio by introducing a collection of EZ Shot 2 single-use aspiration needles for Endoscopic Ultrasound (EUS) procedures.The four unique needles offer excellent puncture capability along with an adjustable sheath designed to help physicians more accurately approach the targeted site.

From Olympus Life Science Solutions 15 Dec 2011

Olympus releases Acecide-C High-Level Disinfectant and Sterilant

Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, announces the release of Acecide-C, a new, peracetic acid-based high-level disinfectant and sterilant.

From Olympus Life Science Solutions 8 Dec 2011